Skip to main content
logo
GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
27.10
-0.64 (-2.31%)
Aug 3, 2026, 4:08 PM HKT

HKG:2595 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Revenue
130.27130.27104.773.73
Revenue Growth
-32.66%24.42%42.00%-
Gross Profit
83.6683.6684.6173.05
Operating Income
-279.98-279.98-305.6-285.83
Net Income
-1,795-1,795-677.64-508.32
Earnings Per Share
-6.07-6.07-2.62-2.31
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
2,0752,075394.92332.2
Total Debt
100.92100.9269.3531.67
Net Cash (Debt)
1,9741,974325.57300.52
Net Cash Growth
627.59%506.26%8.33%-
Net Cash Per Share
6.676.671.261.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-135.7-135.7-206.4-202.06
Capital Expenditures
-0.11-0.11-0.24-0.59
Free Cash Flow
-135.81-135.81-206.64-202.65
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Gross Margin
64.22%64.22%80.81%99.07%
Operating Margin
-214.93%-214.93%-291.87%-387.66%
Pretax Margin
-1377.46%-1377.46%-647.20%-689.40%
Profit Margin
-1377.58%-1377.58%-647.20%-689.40%
FCF Margin
-104.25%-104.25%-197.35%-274.85%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
69.2460.76--